Literature DB >> 20659156

Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.

Leopold Sellner, David Capper, Jochen Meyer, Claus-Dieter Langhans, Christine-Maria Hartog, Heike Pfeifer, Hubert Serve, Anthony D Ho, Jürgen G Okun, Alwin Krämer, Andreas Von Deimling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20659156     DOI： 10.1111/j.1600-0609.2010.01505.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   3.674


× No keyword cloud information.
  16 in total

Review 1.  Progress in acute myeloid leukemia.

Authors:  Tapan M Kadia; Farhad Ravandi; Susan O'Brien; Jorge Cortes; Hagop M Kantarjian
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-09-19

2.  Reply to Struys: Role of biomarker of 2-hydroxyglutarate in acute myeloid leukemia.

Authors:  Yang Shen; Jing-Han Wang; Wen-Lian Chen; Wei Jia; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-17       Impact factor: 11.205

Review 3.  Characterizing DNA methylation alterations from The Cancer Genome Atlas.

Authors:  Daniel J Weisenberger
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  Quantitative Analysis of Oncometabolite 2-Hydroxyglutarate.

Authors:  Bi-Feng Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  TET proteins and 5-methylcytosine oxidation in hematological cancers.

Authors:  Myunggon Ko; Jungeun An; William A Pastor; Sergei B Koralov; Klaus Rajewsky; Anjana Rao
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

6.  Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-Positive AML.

Authors:  Megan E Zavorka Thomas; Xiyuan Lu; Zahra Talebi; Jae Yoon Jeon; Daelynn R Buelow; Alice A Gibson; Muhammad Erfan Uddin; Lindsey T Brinton; Julie Nguyen; Meghan Collins; Alessia Lodi; Shannon R Sweeney; Moray J Campbell; Douglas H Sweet; Alex Sparreboom; Rosa Lapalombella; Stefano Tiziani; Sharyn D Baker
Journal:  Mol Cancer Ther       Date:  2021-09-13       Impact factor: 6.261

7.  Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia.

Authors:  J Balss; C Thiede; T Bochtler; J G Okun; M Saadati; A Benner; S Pusch; G Ehninger; M Schaich; A D Ho; A von Deimling; A Krämer; C E Heilig
Journal:  Leukemia       Date:  2015-11-19       Impact factor: 11.528

Review 8.  Progress in understanding 2-hydroxyglutaric acidurias.

Authors:  Martijn Kranendijk; Eduard A Struys; Gajja S Salomons; Marjo S Van der Knaap; Cornelis Jakobs
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

9.  Mutant IDH1 is required for IDH1 mutated tumor cell growth.

Authors:  Genglin Jin; Christopher J Pirozzi; Lee H Chen; Giselle Y Lopez; Christopher G Duncan; Jie Feng; Ivan Spasojevic; Darell D Bigner; Yiping He; Hai Yan
Journal:  Oncotarget       Date:  2012-08

10.  Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China.

Authors:  Jiang-Han Wang; Wen-Lian Chen; Jun-Min Li; Song-Fang Wu; Tian-Lu Chen; Yong-Mei Zhu; Wei-Na Zhang; Yang Li; Yun-Ping Qiu; Ai-Hua Zhao; Jian-Qing Mi; Jie Jin; Yun-Gui Wang; Qiu-Ling Ma; He Huang; De-Pei Wu; Qin-Rong Wang; Yan Li; Xiao-Jing Yan; Jin-Song Yan; Jian-Yong Li; Shuai Wang; Xiao-Jun Huang; Bing-Shun Wang; Wei Jia; Yang Shen; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 12.779
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.